News
-
-
PRESS RELEASE
Stabilus SE: Adjusted EBIT margin increased in Q3 FY2026 despite a decline in revenue – sale of Fabreeka and Tech Products completed and net debt further reduced
Stabilus SE reports increased Adjusted EBIT margin in Q3 FY2026 despite revenue decline. Sale of Fabreeka and Tech Products completed, net debt reduced. Full-year forecast specified -
-
-
-
-
-
PRESS RELEASE
BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Biophytis provides an update on its Hong Kong joint venture, including key milestones achieved and imminent progress. The joint venture aims to develop BIO101 for sarcopenia in Asian markets -
-